Additionally, highly aggressive MYC-subgroup medulloblastomas, characterized by c-MYC overexpression, have been modeled in mice, providing a robust platform to study their unique pathobiology and develop targeted therapies [23]. The gene discussed is MYC; the disease is medulloblastoma.